CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment SY Neo, Y Yang, J Record, R Ma, X Chen, Z Chen, NP Tobin, E Blake, ... The Journal of clinical investigation 130 (3), 1185-1198, 2020 | 169 | 2020 |
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment K Ito, K Stannard, E Gabutero, AM Clark, SY Neo, S Onturk, H Blanchard, ... Cancer and Metastasis Reviews 31, 763-778, 2012 | 155 | 2012 |
Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells Y Yang, SY Neo, Z Chen, W Cui, Y Chen, M Guo, Y Wang, H Xu, A Kurzay, ... The Journal of Clinical Investigation 130 (10), 5508-5522, 2020 | 64 | 2020 |
Local transmission and global dissemination of New Delhi Metallo-Beta-Lactamase (NDM): a whole genome analysis WX Khong, E Xia, K Marimuthu, W Xu, YY Teo, EL Tan, S Neo, ... BMC genomics 17, 1-13, 2016 | 38 | 2016 |
The multifaceted roles of CXCL9 within the tumor microenvironment SY Neo, A Lundqvist Tumor Microenvironment: The Role of Chemokines–Part A, 45-51, 2020 | 31 | 2020 |
Long non-coding RNA MEG3 promotes cisplatin-induced nephrotoxicity through regulating AKT/TSC/mTOR-mediated autophagy X Jing, J Han, J Zhang, Y Chen, J Yuan, J Wang, S Neo, S Li, X Yu, J Wu International journal of biological sciences 17 (14), 3968, 2021 | 16 | 2021 |
GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma Z Fang, N Zhang, X Yuan, X Xing, X Li, X Qin, Z Liu, S Neo, C Liu, F Kong, ... Journal of Experimental & Clinical Cancer Research 41 (1), 173, 2022 | 13 | 2022 |
A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models AHM Tay, R Prieto-Díaz, S Neo, L Tong, X Chen, V Carannante, B Önfelt, ... Journal for Immunotherapy of Cancer 10 (5), 2022 | 12 | 2022 |
Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25+/CD54+ NK cells Z Chen, Y Yang, SY Neo, H Shi, Y Chen, AK Wagner, K Larsson, L Tong, ... EMBO reports 22 (3), e51329, 2021 | 9 | 2021 |
Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells SY Neo, X Jing, L Tong, D Tong, J Gao, Z Chen, MC De Los Santos, ... Journal for Immunotherapy of Cancer 10 (10), 2022 | 7 | 2022 |
Downregulation and hypermethylation of GABPB1 is associated with aggressive thyroid cancer features X Xing, N Mu, X Yuan, N Wang, CC Juhlin, K Strååt, C Larsson, SY Neo, ... Cancers 14 (6), 1385, 2022 | 6 | 2022 |
Immune monitoring of cancer patients by multi-color flow cytometry SY Neo, A O’Reilly, Y Pico de Coaña Immune Checkpoint Blockade: Methods and Protocols, 49-65, 2019 | 6 | 2019 |
Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction X Chen, EG Sifakis, S Robertson, SY Neo, SH Jun, L Tong, AT Hui Min, ... Proceedings of the National Academy of Sciences 120 (1), e2209856120, 2023 | 5 | 2023 |
CD11c-CD8 spatial cross presentation: A novel approach to link immune surveillance and patient survival in soft tissue sarcoma Y Su, P Tsagkozis, A Papakonstantinou, NP Tobin, O Gultekin, ... Cancers 13 (5), 1175, 2021 | 4 | 2021 |
Mitochondrial dysfunction in CD4+ T effector memory RA+ cells M Strickland, S Lee, SY Neo, A Balachander, I Low, S Mustafah, WI Goh, ... Biology 12 (4), 597, 2023 | 3 | 2023 |
Unravelling the role of obesity and lipids during tumor progression J Zhao, K Lee, HC Toh, KP Lam, SY Neo Frontiers in Pharmacology 14, 1163160, 2023 | 3 | 2023 |
Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer SY Neo, S Xu, J Chong, KP Lam, J Wu Journal for Immunotherapy of Cancer 11 (4), 2023 | 3 | 2023 |
CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression Z Chen, L Tong, SY Neo, S Li, J Gao, S Schlisio, A Lundqvist Oncoimmunology 12 (1), 2175517, 2023 | 2 | 2023 |
Prognostic Profiling of the EMT-Associated and Immunity-Related LncRNAs in Lung Squamous Cell Carcinomas Q Sun, Y Gao, Y Zhang, H Cao, J Liu, SY Neo, K Chen, Y Bi, J Wu Cells 11 (18), 2881, 2022 | 2 | 2022 |
Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease SY Neo, MMS Oliveira, L Tong, Y Chen, Z Chen, S Cismas, N Burduli, ... Journal of Experimental & Clinical Cancer Research 43 (1), 13, 2024 | 1 | 2024 |